InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
2
T+90 hit rate
43%
T+90 mean return
+2.0%
Across 28 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Winningham Rick E, Chairman & CEO. Insider active across 2 companies, notably Theravance Biopharma, Inc.. In total, 36 filings have been recorded. Split: 0 buy · 2 sells. Total volume traded: €327k. History available since 20 May 2021. The latest transaction was filed on 20 May 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations36 total
15,364 shares@ US$9.453.7% of flowOrdinary SharesSEC:0001415889-25-014263:0
2,178 shares@ US$9.350.6% of flowOrdinary SharesSEC:0001415889-25-006684:0
35,129 shares@ US$9.669.4% of flowOrdinary SharesSEC:0001415889-25-005357:0
15,997 shares@ US$9.974.3% of flowOrdinary SharesSEC:0001415889-24-027573:0
3,193 shares@ US$9.570.8% of flowOrdinary SharesSEC:0001415889-24-027297:0
15,997 shares@ US$8.223.4% of flowOrdinary SharesSEC:0001415889-24-022092:0
3,252 shares@ US$7.830.7% of flowOrdinary SharesSEC:0001415889-24-021057:0
3,731 shares0Ordinary SharesSEC:0001765581-24-000079:0
15,997 shares@ US$9.103.9% of flowOrdinary SharesSEC:0001415889-24-014141:0
2,068 shares@ US$9.850.5% of flowOrdinary SharesSEC:0001415889-24-013612:0
300,000 shares0Ordinary SharesSEC:0001415889-24-010328:0
2,704 shares@ US$8.640.6% of flowOrdinary SharesSEC:0001415889-24-008630:0
37,196 shares@ US$8.928.9% of flowOrdinary SharesSEC:0001415889-24-004968:0
15,804 shares@ US$10.374.3% of flowOrdinary SharesSEC:0001415889-23-015454:0
15,804 shares@ US$9.704.1% of flowOrdinary SharesSEC:0001415889-23-012522:0
3,075 shares0Ordinary SharesSEC:0001765581-23-000094:0
15,804 shares@ US$11.214.7% of flowOrdinary SharesSEC:0001415889-23-008676:0
330,000 shares0Ordinary SharesSEC:0001415889-23-004277:0
37,420 shares@ US$10.4410.5% of flowOrdinary SharesSEC:0001415889-23-003078:0
9,000 sharesOrdinary SharesSEC:0001415889-22-012648:0
15,804 shares@ US$10.854.8% of flowOrdinary SharesSEC:0001415889-22-011673:0
15,804 shares@ US$9.344.2% of flowOrdinary SharesSEC:0001415889-22-008985:0
2,561 shares0Ordinary SharesSEC:0001765581-22-000102:0
11,025 shares@ US$8.740.011% mcap8.6% of flowOrdinary SharesSEC:0001415889-22-005633:0
170,000 shares0Ordinary SharesSEC:0001415889-22-002078:0
25 of 36 declarations
About Winningham Rick E
Rick E. Winningham is the Chief Executive Officer of Theravance Biopharma, Inc. and Jazz Pharmaceuticals plc. With extensive experience in the pharmaceutical industry, he leads the development and marketing strategies for the products of both companies.
